previous compound ID: 1299 next compound
InChIKey: LPXQRXLUHJKZIE-UHFFFAOYSA-N
SMILES: C12=NNNC1=NC(=NC2=O)N

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"SD Macknight" "E Matthes" "B Kus" "GW Carlile" "D Rotin" "J Goepp" "JW Hanrahan" "J Liao" "R Robert" "DY Thomas"

chemical graph of compound 1299





CID is 8646
synonyms found at PubChem are:
8-AZAGUANINE, 134-58-7, Guanazolo, Azaguanine-8, Azaguanine, Guanazol, Pathocidin, Pathocidine, Triazologuanine, Azan, 8 AG, 5-Amino-1H-v-triazolo(d)pyrimidin-7-ol, 5-Amino-1H-[1,2,3]triazolo[4,5-d]pyrimidin-7(6H)-one, AZG, SK 1150, 5-Amino-7-hydroxy-1H-v-triazolo(d)pyrimidine, NSC-749, 5-Amino-1,6-dihydro-7H-v-triazolo(4,5-d)pyrimidin-7-one, 5-Amino-1,4-dihydro-7H-1,2,3-triazolo(4,5-d)pyrimidin-7-one, 5-Amino-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7-ol, SF-337, 2-Amino-6-oxy-8-azapurine, C4H4N6O, NSC 223526, CCRIS 2758, NSC749, 2-Amino-6-hydroxy-8-azapurine, B-28, CHEBI:63486, 7H-1,2,3-Triazolo[4,5-d]pyrimidin-7-one, 5-amino-1,4-dihydro-, 8-AzaG, NSC 749, 5-amino-1H-triazolo[4,5-d]pyrimidin-7-ol, AZAGUANINE,8, UNII-Q150359I72, v-Triazolo(4,5-d)pyrimidin-7-ol, 5-amino-, EINECS 205-148-1, 5-amino-2,3-dihydrotriazolo[4,5-d]pyrimidin-7-one, AI3-25015, MLS001074752, LPXQRXLUHJKZIE-UHFFFAOYSA-N, 5-Amino-3,6-dihydro-7H-[1,2,3]triazolo[4,5-d]pyrimidin-7-one, 7H-1,2,3-Triazolo(4,5-d)pyrimidin-7-one, 5-amino-1,4-dihydro-, MFCD00056937, NSC223526, SMR000112575, 7H-v-Triazolo(4,5-d)pyrimidin-7-one, 5-amino-1,6-dihydro-, 5-Amino-1H-triazolo(4,5-d)pyrimidin-7-ol, Q150359I72, 3-amino-2,4,7,8,9-pentazabicyclo[4.3.0]nona-1,3,6-trien-5-one, v-Triazolo[4, 5-amino-, 5-AMINO-1H-[1,2,3]TRIAZOLO[4,5-D]PYRIMIDIN-7-OL, 5-imino-4,6-dihydro-3H-1,2,3-triazolo[5,4-d]pyrimidin-7-one, 7H-1,2,3-Triazolo(4,5-d)pyrimidinone, 5-amino-1,4-dihydro-, WLN: T56 BNNM FVM INJ HZ, 5-AMINO-3,6-DIHYDRO-(1,2,3)TRIAZOLO(4,5-D)PYRIMIDIN-7-ONE, 7H-1,2,3-Triazolo[4,5-d]pyrimidin-7-one,5-amino-3,6-dihydro-, 7H-v-Triazolo[4, 5-amino-1,6-dihydro-, 7H-1,3-Triazolo[4,5-d]pyrimidin-7-one, 5-amino-1,4-dihydro-, 8-azaguanin, Azaguanine, 8, Prestwick_40, degrees (c)E cent, ACMC-1BSCA, AC1Q6AZZ, Prestwick0_000001, Prestwick1_000001, Prestwick2_000001, Prestwick3_000001, D01OHV, Epitope ID:167837, NCIMech_000065, AC1L1RF4, AC1Q52ZT, cid_8646, Oprea1_163604, Oprea1_695327, Oprea1_862850, SCHEMBL26816, BSPBio_000001, KSC519E8N, SPBio_001922, BPBio1_000003, CHEMBL374107, Jsp002100, DTXSID0074508, SCHEMBL16056969, BDBM96998, CTK4B9286, CTK7D5145, MolPort-002-047-086, MolPort-002-507-918, MolPort-004-963-947, MolPort-005-974-065, MolPort-009-199-364, MolPort-015-161-801, HMS1568A03, HMS2095A03, HMS2269M18, HMS3652J09, HMS3712A03, ML068, ALBB-023426, HY-B1468, KS-00000IS4, ANW-19689, CCG-35353, s4194, SBB000107, STK961684, ZINC96321491, AKOS002271137, AKOS003382261, AKOS006223655, AKOS015854480, AKOS022504735, AKOS026750385, AKOS028109237, CCG-220001, DB01667, MCULE-1863790805, NSC-223526, VZ35729, NCGC00016399-01, NCGC00188264-01, AJ-50842, AN-43735, DS-16103, NCI60_041639, SC-09024, ST025228, ST088035, LS-156822, A0625, CS-0013169, FT-0621501, K-4258, 134A587, AP-770/40205766, SR-01000763820, 2- degrees +/->>u-6-No-8-micro feminineOOaNssE, 5-amino-3,6-dihydrotriazolo[4,5-d]pyrimidin-7-one, 5-amino-3H-1,2,3-triazolo[5,4-d]pyrimidin-7-ol, Q-200564, SR-01000763820-2, 2- degrees +/->>u-6-oC>>u-8-micro feminineOOaNssE, I14-51392, 3H-1,2,3-triazolo[4,5-d]pyrimidin-7-ol, 5-amino-, 5-amino-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7(6H)-one, 5-amino-3H,6H,7H-[1,2,3]triazolo[4,5-d]pyrimidin-7-one, 5-azanyl-2,3-dihydro-[1,2,3]triazolo[4,5-d]pyrimidin-7-one, {7H-v-Triazolo[4,5-d]pyrimidin-7-one,} 5-amino-1, 6-dihydro-, 5-Amino-3,6-dihydro-7H-[1,2,3]triazolo[4,5-d]pyrimidin-7-one #, 7H-1,2,3-triazolo[4,5-d]pyrimidin-7-one, 5-amino-3,6-dihydro-, {7H-1,2,3-Triazolo[4,5-d]pyrimidin-7-one,} 5-amino-1,4-dihydro-, 5-imino-3,4,5,6-tetrahydro-7H-[1,2,3]triazolo[4,5-d]pyrimidin-7-one, 7H-1,2,3-Triazolo(4,5-d)pyrimidin-7-one, 5-amino-1,4-dihydro- (9CI), 8-Azaguanine, Hybri-Max(TM), gamma-irradiated, powder, BioXtra, suitable for hybridoma, 1850358-61-0